Automated flow injection fluorimetric determination and dissolution studies of bumetanide in pharmaceuticals

A novel, sensitive and automated flow injection (FI) method with fluorimetric detection based on the strong fluorescence in alkaline medium has been developed for the assay, content uniformity and automated dissolution studies of bumetanide in pharmaceutical dosage forms. A fully automated FIA system controlled by home-made software (FIA-MOD 2.2.) was used for optimising the chemical and manifold parameters and running of routine measurements. The optimum excitation wavelength for bumetanide is 314nm and emission wavelength =" border=0 src="/.dejavu/.tact/lib1/art410/pcdata/html_gif/charset.gif/bmd.gif"370nm. The measurement throughput is 60h-1 using 110?l sample volume. The useful concentration range is 0.05-10.0?gml-1 with an R.S.D. of 0.46% (n=3; c=1.0?gml-1). Common excipients for tablets and injections were found not interfering. The assay results of two commercial drug formulations (tablets and injections) obtained with the proposed method agreed well with those obtained with the current USP method (HPLC-UV detection). Using this automated method the complete dissolution profile of bumetanide tablets was obtained.